[HTML][HTML] Highlights in resistance mechanism pathways for combination therapy
Combination chemotherapy has been a mainstay in cancer treatment for the last 60 years.
Although the mechanisms of action and signaling pathways affected by most treatments with …
Although the mechanisms of action and signaling pathways affected by most treatments with …
Treatment of head and neck squamous cell carcinoma recurrences and distant metastases: Highlights of the 2018 ASCO meeting
L Bußmann, A Münscher, CJ Busch - HNO, 2018 - Springer
This year, the treatment of patients with recurrent or metastatic head and neck squamous
cell carcinoma (R/M-HNSCC) was mainly dominated by immunotherapy. The corresponding …
cell carcinoma (R/M-HNSCC) was mainly dominated by immunotherapy. The corresponding …
Treatment of head and neck squamous cell carcinoma recurrences and distant metastases: Highlights of the ASCO Meeting 2016
L Bußmann, CJ Busch, R Knecht - HNO, 2016 - Springer
This year particularly phase II studies were presented at the 2016 ASCO Annual Meeting, in
which new drugs (monoclonal antibodies, small molecules) were investigated in patients …
which new drugs (monoclonal antibodies, small molecules) were investigated in patients …